An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors

Clinical trial NCT00524524 · COMPLETED

Trial details

NCT number: NCT00524524
Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2007-08-01
Primary completion: 2008-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.